Moderna, Inc. vs Unity Biotechnology, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $33 M for Unity Biotechnology, Inc., 2731 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Unity Biotechnology, Inc.). Unity Biotechnology, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Both made a net loss: $2.8 B for Moderna, Inc. and $94 M for Unity Biotechnology, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Moderna, Inc. MRNA · #275 in the world | Unity Biotechnology, Inc. UBX |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | 2011 |
| Size | ||
| Market cap | $90.1 B | $33 M* |
| Revenue | $1.9 B | $0 M |
| Net income | $-2.8 B | $-94 M▲ best |
| Employees | 4,700 | — |
| Valuation | ||
| Price to sales | 35.7× | — |
| Price to book | 10.4× | — |
| Free cash flow yield | -2.3% | — |
| Profitability | ||
| Gross margin | 55.4% | — |
| Operating margin | -158.1% | — |
| Net margin | -145.2% | — |
| Return on equity | -28.9% | — |
| Growth | ||
| Revenue growth | -39.9% | — |
| Revenue growth, 3 years a year | -53.4% | — |
| Financial strength | ||
| Debt to equity | 0.1× | — |
| Cash | ||
| Free cash flow margin | -106.2% | — |
| Shareholder returns | ||
| Shareholder yield | 0.0% | — |
| Strength scores | ||
| Piotroski F-score | 3 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Moderna, Inc. or Unity Biotechnology, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $33 M for Unity Biotechnology, Inc., 2731 times as much (market caps of Oct 30, 2026 for Moderna, Inc. and Jan 5, 2024 for Unity Biotechnology, Inc.). Unity Biotechnology, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Moderna, Inc. or Unity Biotechnology, Inc.?
Both made a net loss: $2.8 B for Moderna, Inc. and $94 M for Unity Biotechnology, Inc.
More about Moderna, Inc.
More about Unity Biotechnology, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.